From the group archive · This article reflects its original publication date. For current information, see our latest publications and official disclosures.
| NEXGRAM HOLDINGS BERHAD |
| Type | Announcement |
| Subject | TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) NON RELATED PARTY TRANSACTIONS |
| Description |
SALES AGREEMENT ENTERED INTO BETWEEN NEXGRAM INDUSTRIES SDN BHD WITH SHANGHAI LIANGRUN BIOMEDICINE TECHNOLOGY CO., LTD FOR DISTRIBUTING TRI-G'S COVID-19 MEDICAL DEVICES AND AS AN AUTHORISED DISTRIBUTOR FOR MALAYSIA |
|
The Board of Directors of Nexgram is pleased to announce that Nexgram Industries Sdn Bhd. (“NISB”), a wholly-owned subsidiary of the Company has on 12 March 2020 entered into a Sales Agreement (“Agreement”) with Shanghai Liangrun Biomedicine Technology Co., Ltd (“Shanghai Liangrun”) to sell their product, Diagnostic Kit for Antibody IgM/IgG of Novel Coronavirus COVID-19 (“Diagnostic Kit”) in Malaysia and Indonesia. Besides, Shanghai Liangrun has appointed NISB as the authorised dealer to seek the approvals from the Ministry of Health in Malaysia and relevant authorities in Indonesia for the distribution of the Diagnostic Kit.
Please refer to the attachment for details of the announcement.
This announcement is dated 27 May 2020. |
|
Please refer attachment below.
Announcement Info
| Company Name | NEXGRAM HOLDINGS BERHAD |
| Stock Name | NEXGRAM |
| Date Announced | 27 May 2020 |
| Category | General Announcement for PLC |
| Reference Number | GA1-27052020-00086 |